Heavily immunosuppressed patients undergoing anticancer immunotherapy face increased risk of severe infections

Immune checkpoint inhibitors (ICIs) tin beforehand antitumor responses but tin besides origin adverse effects that necessitate attraction with immunosuppressive drugs. A caller retrospective survey by Mass General Brigham Cancer Institute investigators recovered that patients who received ICIs and aggregate immunosuppressive therapies were astatine higher hazard of superior infections. Nearly fractional of the infections were severe, life-threatening oregon fatal. The results are published successful Journal of the National Comprehensive Cancer Network.